Cargando…

COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey

BACKGROUND: Coronavirus disease 2019 (COVID-19) has already claimed over four million lives globally and over 800 deaths in Ghana. The COVID-19 vaccine is a key intervention towards containing the pandemic. Over three billion doses of the vaccine have already been administered globally and over 800,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhassan, Robert Kaba, Aberese-Ako, Matilda, Doegah, Phidelia Theresa, Immurana, Mustapha, Dalaba, Maxwel Ayindenaba, Manyeh, Alfred Kwesi, Klu, Desmond, Acquah, Evelyn, Ansah, Evelyn Korkor, Gyapong, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674411/
https://www.ncbi.nlm.nih.gov/pubmed/34915939
http://dx.doi.org/10.1186/s41182-021-00357-5
_version_ 1784615642493616128
author Alhassan, Robert Kaba
Aberese-Ako, Matilda
Doegah, Phidelia Theresa
Immurana, Mustapha
Dalaba, Maxwel Ayindenaba
Manyeh, Alfred Kwesi
Klu, Desmond
Acquah, Evelyn
Ansah, Evelyn Korkor
Gyapong, Margaret
author_facet Alhassan, Robert Kaba
Aberese-Ako, Matilda
Doegah, Phidelia Theresa
Immurana, Mustapha
Dalaba, Maxwel Ayindenaba
Manyeh, Alfred Kwesi
Klu, Desmond
Acquah, Evelyn
Ansah, Evelyn Korkor
Gyapong, Margaret
author_sort Alhassan, Robert Kaba
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) has already claimed over four million lives globally and over 800 deaths in Ghana. The COVID-19 vaccine is a key intervention towards containing the pandemic. Over three billion doses of the vaccine have already been administered globally and over 800,000 doses administered in Ghana, representing less than 5% vaccination coverage. Fear, uncertainty, conspiracy theories and safety concerns remain important threats to, a successful rollout of the vaccine if not managed well. OBJECTIVE: Ascertain the predictors of citizens’ probability of participating in a COVID-19 vaccine trial and subsequently accept the vaccine when given the opportunity. METHODOLOGY: The study was an online nation-wide survey among community members (n = 1556) from 18th September to 23rd October, 2020 in the 16 regions in Ghana. Binary probit regression analysis with marginal effect estimations was employed to ascertain the predictors of community members’ willingness to participate in a COVID-19 vaccine trial and uptake the vaccine. RESULTS: Approximately 60% of respondents said they will not participate in a COVID-19 vaccine trial; 65% will take the vaccine, while 69% will recommend it to others. Willingness to voluntarily participate in COVID-19 vaccine trial, uptake the vaccine and advise others to do same was higher among adults aged 18–48 years, the unmarried and males (p < 0.05). Significant predictors of unwillingness to participate in the COVID-19 vaccine trial and uptake of the vaccine are: married persons, females, Muslims, older persons, residents of less urbanised regions and persons with lower or no formal education (p < 0.05). Predominant reasons cited for unwillingness to participate in a COVID-19 vaccine trial and take the vaccine included fear, safety concerns, lack of trust in state institutions, uncertainty, political connotations, spiritual and religious beliefs. CONCLUSION: The probability of accepting COVID-19 vaccine among the adult population in Ghana is high but the country should not get complacent because fear, safety and mistrust are important concerns that have the potential to entrench vaccine hesitancy. COVID-19 vaccine rollout campaigns should be targeted and cognisant of the key predictors of citizens’ perceptions of the vaccine. These lessons when considered will promote Ghana’s efforts towards vaccinating at least 20 million people to attain herd immunity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41182-021-00357-5.
format Online
Article
Text
id pubmed-8674411
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86744112021-12-16 COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey Alhassan, Robert Kaba Aberese-Ako, Matilda Doegah, Phidelia Theresa Immurana, Mustapha Dalaba, Maxwel Ayindenaba Manyeh, Alfred Kwesi Klu, Desmond Acquah, Evelyn Ansah, Evelyn Korkor Gyapong, Margaret Trop Med Health Research BACKGROUND: Coronavirus disease 2019 (COVID-19) has already claimed over four million lives globally and over 800 deaths in Ghana. The COVID-19 vaccine is a key intervention towards containing the pandemic. Over three billion doses of the vaccine have already been administered globally and over 800,000 doses administered in Ghana, representing less than 5% vaccination coverage. Fear, uncertainty, conspiracy theories and safety concerns remain important threats to, a successful rollout of the vaccine if not managed well. OBJECTIVE: Ascertain the predictors of citizens’ probability of participating in a COVID-19 vaccine trial and subsequently accept the vaccine when given the opportunity. METHODOLOGY: The study was an online nation-wide survey among community members (n = 1556) from 18th September to 23rd October, 2020 in the 16 regions in Ghana. Binary probit regression analysis with marginal effect estimations was employed to ascertain the predictors of community members’ willingness to participate in a COVID-19 vaccine trial and uptake the vaccine. RESULTS: Approximately 60% of respondents said they will not participate in a COVID-19 vaccine trial; 65% will take the vaccine, while 69% will recommend it to others. Willingness to voluntarily participate in COVID-19 vaccine trial, uptake the vaccine and advise others to do same was higher among adults aged 18–48 years, the unmarried and males (p < 0.05). Significant predictors of unwillingness to participate in the COVID-19 vaccine trial and uptake of the vaccine are: married persons, females, Muslims, older persons, residents of less urbanised regions and persons with lower or no formal education (p < 0.05). Predominant reasons cited for unwillingness to participate in a COVID-19 vaccine trial and take the vaccine included fear, safety concerns, lack of trust in state institutions, uncertainty, political connotations, spiritual and religious beliefs. CONCLUSION: The probability of accepting COVID-19 vaccine among the adult population in Ghana is high but the country should not get complacent because fear, safety and mistrust are important concerns that have the potential to entrench vaccine hesitancy. COVID-19 vaccine rollout campaigns should be targeted and cognisant of the key predictors of citizens’ perceptions of the vaccine. These lessons when considered will promote Ghana’s efforts towards vaccinating at least 20 million people to attain herd immunity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41182-021-00357-5. BioMed Central 2021-12-16 /pmc/articles/PMC8674411/ /pubmed/34915939 http://dx.doi.org/10.1186/s41182-021-00357-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Alhassan, Robert Kaba
Aberese-Ako, Matilda
Doegah, Phidelia Theresa
Immurana, Mustapha
Dalaba, Maxwel Ayindenaba
Manyeh, Alfred Kwesi
Klu, Desmond
Acquah, Evelyn
Ansah, Evelyn Korkor
Gyapong, Margaret
COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey
title COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey
title_full COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey
title_fullStr COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey
title_full_unstemmed COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey
title_short COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey
title_sort covid-19 vaccine hesitancy among the adult population in ghana: evidence from a pre-vaccination rollout survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674411/
https://www.ncbi.nlm.nih.gov/pubmed/34915939
http://dx.doi.org/10.1186/s41182-021-00357-5
work_keys_str_mv AT alhassanrobertkaba covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT abereseakomatilda covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT doegahphideliatheresa covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT immuranamustapha covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT dalabamaxwelayindenaba covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT manyehalfredkwesi covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT kludesmond covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT acquahevelyn covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT ansahevelynkorkor covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey
AT gyapongmargaret covid19vaccinehesitancyamongtheadultpopulationinghanaevidencefromaprevaccinationrolloutsurvey